Kytril (BioDeep_00000645328)

   


代谢物信息卡片


Granisetron hydrochloride

化学式: C18H25ClN4O (348.171679)
中文名称: 盐酸格拉司琼
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl
InChI: 1H

描述信息

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
D005765 - Gastrointestinal Agents > D000932 - Antiemetics
D002491 - Central Nervous System Agents
Granisetron (Hydrochloride) (BRL 43694A) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.

同义名列表

4 个代谢物同义名

Granisetron hydrochloride; Kytril; BRL 43694A; Granisetron (Hydrochloride)



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Min Zeng, Junxiang Li, Tingting Zheng, Xi Yan, Feng Yuan, Bingbing Xiang. Electropress Needle Stimulation for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Sleeve Gastrectomy: A Prospective, Randomized Controlled Trial. Obesity surgery. 2023 09; 33(9):2831-2840. doi: 10.1007/s11695-023-06752-7. [PMID: 37507634]
  • Fei Liu, Liu-Lin Xiong, Ting-Ting Li, Yan-Jun Chen, Wei Ma, Qi-Jun Li, Qian Li, Ting-Hua Wang. Analgesic Effects and Adverse Reactions of Lidocaine for Patient-Controlled Intravenous Analgesia on Patients Undergoing Open Hepatectomy: A Retrospective Analysis. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses. 2023 Feb; 38(1):39-44. doi: 10.1016/j.jopan.2022.05.069. [PMID: 35989234]
  • Mitsuhiro Goda, Masaya Kanda, Toshihiko Yoshioka, Ami Yoshida, Yoichi Murai, Yoshito Zamami, Fuka Aizawa, Takahiro Niimura, Hirofumi Hamano, Naoto Okada, Kenta Yagi, Masayuki Chuma, Yuki Izawa-Ishizawa, Keisuke Ishizawa. Effects of 5-HT₃ receptor antagonists on cisplatin-induced kidney injury. Clinical and translational science. 2021 09; 14(5):1906-1916. doi: 10.1111/cts.13045. [PMID: 33982438]
  • Ashkan Divanbeigi, Mohammad Nasehi, Salar Vaseghi, Sepideh Amiri, Mohammad-Reza Zarrindast. Tropisetron But Not Granisetron Ameliorates Spatial Memory Impairment Induced by Chronic Cerebral Hypoperfusion. Neurochemical research. 2020 Nov; 45(11):2631-2640. doi: 10.1007/s11064-020-03110-2. [PMID: 32797381]
  • Mohammad Reza Zirak, Gholamreza Karimi, Reza Rahimian, Amir Hossein Jafarian, A Wallace Hayes, Soghra Mehri. Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats. European journal of pharmacology. 2020 Sep; 883(?):173310. doi: 10.1016/j.ejphar.2020.173310. [PMID: 32619674]
  • Qinghua Wu, Kamil Kuca, Eugenie Nepovimova, Wenda Wu. Type A Trichothecene Diacetoxyscirpenol-Induced Emesis Corresponds to Secretion of Peptide YY and Serotonin in Mink. Toxins. 2020 06; 12(6):. doi: 10.3390/toxins12060419. [PMID: 32630472]
  • N Konthapakdee, L Grundy, T O'Donnell, S Garcia-Caraballo, S M Brierley, D Grundy, D M Daly. Serotonin exerts a direct modulatory role on bladder afferent firing in mice. The Journal of physiology. 2019 11; 597(21):5247-5264. doi: 10.1113/jp278751. [PMID: 31520534]
  • Mahmoud A Tantawy, Soheir Alweshahy, Dalia A Elshabasy, Nadia F Youssef. Simultaneous Determination of Co-administrated Deflazacort, Aprepitant and Granisetron in Dosage Forms and Spiked Human Plasma by RP-HPLC/PAD. Journal of chromatographic science. 2019 Oct; 57(9):790-798. doi: 10.1093/chromsci/bmz062. [PMID: 31504281]
  • Y Yu, H Fan, Y Cheng, J L Sun. [Effect of intravenous granisetron combined and acupuncture point injection at PC6(Neiguan) with 0.9\% sodium chlorideon postoperative nausea and vomiting after gynecological laparoscopy]. Zhonghua yi xue za zhi. 2019 Sep; 99(33):2606-2610. doi: 10.3760/cma.j.issn.0376-2491.2019.33.010. [PMID: 31510721]
  • Shenhai Gong, Zhengzheng Yan, Zhanguo Liu, Mengwei Niu, Heng Fang, Na Li, Chenyang Huang, Lei Li, Guiming Chen, Haihua Luo, Xiaojiao Chen, Hongwei Zhou, Jingjuan Hu, Wei Yang, Qiaobing Huang, Bernd Schnabl, Ping Chang, Timothy R Billiar, Yong Jiang, Peng Chen. Intestinal Microbiota Mediates the Susceptibility to Polymicrobial Sepsis-Induced Liver Injury by Granisetron Generation in Mice. Hepatology (Baltimore, Md.). 2019 04; 69(4):1751-1767. doi: 10.1002/hep.30361. [PMID: 30506577]
  • Rui Chen, Xia Chen, Hongyun Wang, Wen Zhong, Eun Sil Oh, Min Soo Park, Yuji Kumagai, Li Zhou, Fumiko Nagahama, Pei Hu. Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study
. International journal of clinical pharmacology and therapeutics. 2019 Jan; 57(1):24-31. doi: 10.5414/cp203327. [PMID: 30336808]
  • Yukari Tsubata, Mika Nakao, Yoshihiro Amano, Takamasa Hotta, Megumi Hamaguchi, Tamio Okimoto, Kiyotaka Miura, Shunichi Hamaguchi, Takashige Kuraki, Masayuki Itakura, Takeshi Isobe. Translational and Randomized Study of 5-HT3 Receptor Antagonists for Evaluation of Chemotherapy-induced Nausea and Vomiting Related Biomarkers. The journal of medical investigation : JMI. 2019; 66(3.4):269-274. doi: 10.2152/jmi.66.269. [PMID: 31656287]
  • Rehab Abdelmonem, Mohamed El Nabarawi, Alshaimaa Attia. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats. Drug delivery. 2018 Nov; 25(1):70-77. doi: 10.1080/10717544.2017.1413447. [PMID: 29228824]
  • Cunying Huang, Huihui Wan, Jing Zhang, Hongmin Zhong, Juan Li, YuMing Sun, Qing Wang, Hua Zhang. Quantification of ondansetron, granisetron and tropisetron in goat plasma using hydrophilic interaction liquid chromatography-solid phase extraction coupled with hydrophilic interaction liquid chromatography-triple quadrupole tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2018 Sep; 1095(?):50-58. doi: 10.1016/j.jchromb.2018.07.009. [PMID: 30053687]
  • André Dallmann, Ibrahim Ince, Katrin Coboeken, Thomas Eissing, Georg Hempel. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways. Clinical pharmacokinetics. 2018 06; 57(6):749-768. doi: 10.1007/s40262-017-0594-5. [PMID: 28924743]
  • Guozhong Yang, Meilin He, Suohui Zhang, Man Wu, Yunhua Gao. An acryl resin-based swellable microneedles for controlled release intradermal delivery of granisetron. Drug development and industrial pharmacy. 2018 May; 44(5):808-816. doi: 10.1080/03639045.2017.1414230. [PMID: 29216752]
  • Mihoko Morita, Shinji Kishi, Miyuki Ookura, Yasufumi Matsuda, Katsunori Tai, Takahiro Yamauchi, Takanori Ueda. Efficacy of aprepitant for CHOP chemotherapy-induced nausea, vomiting, and anorexia. Current problems in cancer. 2017 Nov; 41(6):419-425. doi: 10.1016/j.currproblcancer.2017.09.001. [PMID: 29061362]
  • Sheila A Doggrell. Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?. Expert opinion on pharmacotherapy. 2017 Jul; 18(10):1019-1026. doi: 10.1080/14656566.2017.1342809. [PMID: 28612633]
  • Yasmin Moustafa Ahmed, Basim Anwar Shehata Messiha, Ali Ahmed Abo-Saif. Granisetron and carvedilol can protect experimental rats againstadjuvant-induced arthritis. Immunopharmacology and immunotoxicology. 2017 Apr; 39(2):97-104. doi: 10.1080/08923973.2017.1286502. [PMID: 28211304]
  • Martha L Bustos, Yang Zhao, Huijun Chen, Steve N Caritis, Raman Venkataramanan. Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting. Pharmacotherapy. 2016 12; 36(12):1238-1244. doi: 10.1002/phar.1860. [PMID: 27809336]
  • Katja Rezonja, Tomaz Mars, Ales Jerin, Gordana Kozelj, Neva Pozar-Lukanovic, Maja Sostaric. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia. BMC anesthesiology. 2016 10; 16(1):101. doi: 10.1186/s12871-016-0254-6. [PMID: 27765010]
  • Steve Caritis, Yang Zhao, Hui-Jun Chen, Raman Venkataramanan. Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy. American journal of obstetrics and gynecology. 2016 07; 215(1):93.e1-4. doi: 10.1016/j.ajog.2016.01.163. [PMID: 26812081]
  • Qi Shi, Wen Li, Hongjia Li, Qiqi Le, Shanshan Liu, Shaoqi Zong, Leizhen Zheng, Fenggang Hou. Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison. Oncotarget. 2016 Apr; 7(17):24402-14. doi: 10.18632/oncotarget.8255. [PMID: 27015550]
  • Jennyfer Cázares-Delgadillo, Adriana Ganem-Rondero, Virginia Merino, Yogeshvar N Kalia. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2016 Mar; 85(?):31-8. doi: 10.1016/j.ejps.2016.01.027. [PMID: 26826281]
  • Yang Zhao, Hui-Jun Chen, Steve Caritis, Raman Venkataramanan. Development and validation of a sensitive liquid chromatographic-tandem mass spectrometric method for the simultaneous analysis of granisetron and 7-hydroxy granisetron in human plasma and urine samples: application in a clinical pharmacokinetic study in pregnant subject. Biomedical chromatography : BMC. 2016 Feb; 30(2):149-54. doi: 10.1002/bmc.3530. [PMID: 26053159]
  • Hiroshi Kitamura, Atsushi Takahashi, Hiroshi Hotta, Ryuichi Kato, Yasuharu Kunishima, Fumiyasu Takei, Hiroki Horita, Naoya Masumori. Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients. International journal of urology : official journal of the Japanese Urological Association. 2015 Oct; 22(10):911-4. doi: 10.1111/iju.12842. [PMID: 26087891]
  • Judith A Smith, Justin M Julius, Anjali Gaikwad, Pamela D Berens, Joseph Alcorn, Kenneth J Moise, Jerrie S Refuerzo. Evaluating the potential effect on fetal tissue after exposure to granisetron during pregnancy. Reproductive toxicology (Elmsford, N.Y.). 2015 Jun; 53(?):92-8. doi: 10.1016/j.reprotox.2015.02.011. [PMID: 25813292]
  • Howida K Ibrahim, Nevine S Abdel Malak, Sally A Abdel Halim. Formulation of Convenient, Easily Scalable, and Efficient Granisetron HCl Intranasal Droppable Gels. Molecular pharmaceutics. 2015 Jun; 12(6):2019-25. doi: 10.1021/mp500825n. [PMID: 25936630]
  • Anita Barzegar-Fallah, Houman Alimoradi, Firouzeh Asadi, Ahmad Reza Dehpour, Mojgan Asgari, Massoumeh Shafiei. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Clinical and experimental pharmacology & physiology. 2015 Apr; 42(4):361-8. doi: 10.1111/1440-1681.12373. [PMID: 25676798]
  • Hironori Nakamura, Haruko Yokoyama, Risa Takayanagi, Koichi Yoshimoto, Akihiro Nakajima, Kiyoshi Okuyama, Osamu Iwase, Yasuhiko Yamada. Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin. European journal of drug metabolism and pharmacokinetics. 2015 Mar; 40(1):39-44. doi: 10.1007/s13318-014-0175-z. [PMID: 24470169]
  • Ying Zhou, Ji Jiang, Pei Hu, Hongyun Wang. A high-performance liquid chromatography-tandem mass spectrometry method coupled with protein precipitation for determination of granisetron in human plasma and its application to a comparative pharmacokinetic study. Biomedical chromatography : BMC. 2014 Dec; 28(12):1597-600. doi: 10.1002/bmc.3233. [PMID: 24811001]
  • Justin M Julius, Andrew Tindall, Kenneth J Moise, Jerrie S Refuerzo, Pamela D Berens, Judith A Smith. Evaluation of the maternal-fetal transfer of granisetron in an ex vivo placenta perfusion model. Reproductive toxicology (Elmsford, N.Y.). 2014 Nov; 49(?):43-7. doi: 10.1016/j.reprotox.2014.06.003. [PMID: 25019977]
  • Wenda Wu, Melissa A Bates, Steven J Bursian, Brenna Flannery, Hui-Ren Zhou, Jane E Link, Haibin Zhang, James J Pestka. Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin). Toxicological sciences : an official journal of the Society of Toxicology. 2013 May; 133(1):186-95. doi: 10.1093/toxsci/kft033. [PMID: 23457120]
  • Hea-Jeong Doh, Yunjin Jung, Prabagar Balakrishnan, Hyun-Jong Cho, Dae-Duk Kim. A novel lipid nanoemulsion system for improved permeation of granisetron. Colloids and surfaces. B, Biointerfaces. 2013 Jan; 101(?):475-80. doi: 10.1016/j.colsurfb.2012.07.019. [PMID: 23010057]
  • Hironori Nakamura, Haruko Yokoyama, Koichi Yoshimoto, Akihiro Nakajima, Kiyoshi Okuyama, Osamu Iwase, Yasuhiko Yamada. Method for individualized evaluation of antiemetic effect induced by 5-HT3 receptor antagonist. Biological & pharmaceutical bulletin. 2013; 36(5):780-7. doi: 10.1248/bpb.b12-00946. [PMID: 23459393]
  • Junki Endo, Hirotoshi Iihara, Maya Yamada, Koumei Yanase, Fumihiko Kamiya, Fumitaka Ito, Norihiko Funaguchi, Yasushi Ohno, Shinya Minatoguchi, Yoshinori Itoh. A randomized controlled non-inferiority study comparing the antiemetic effect between intravenous granisetron and oral azasetron based on estimated 5-HT3 receptor occupancy. Anticancer research. 2012 Sep; 32(9):3939-47. doi: . [PMID: 22993341]
  • A J Thompson, M H P Verheij, I J P de Esch, S C R Lummis. VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors. The Journal of pharmacology and experimental therapeutics. 2012 May; 341(2):350-9. doi: 10.1124/jpet.111.190769. [PMID: 22306960]
  • S C R Lummis, A J Thompson, M Bencherif, H A Lester. Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor. The Journal of pharmacology and experimental therapeutics. 2011 Oct; 339(1):125-31. doi: 10.1124/jpet.111.185306. [PMID: 21775477]
  • Toshiaki Takahashi, Yukiko Nakamura, Asuka Tsuya, Haruyasu Murakami, Masahiro Endo, Nobuyuki Yamamoto. Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients. Cancer chemotherapy and pharmacology. 2011 Sep; 68(3):653-9. doi: 10.1007/s00280-010-1519-2. [PMID: 21125277]
  • Manish Yadav, Ajay Gupta, Puran Singhal, Pranav S Shrivastav. Development and validation of a selective and rapid LC-MS-MS method for the quantification of abacavir in human plasma. Journal of chromatographic science. 2010 Sep; 48(8):654-62. doi: 10.1093/chromsci/48.8.654. [PMID: 20819295]
  • Koji Yakabi, Susumu Kurosawa, Mitsuo Tamai, Mitsutoshi Yuzurihara, Miwa Nahata, Shino Ohno, Shoki Ro, Shingo Kato, Toru Aoyama, Tomoya Sakurada, Hidehiko Takabayashi, Tomohisa Hattori. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction. Regulatory peptides. 2010 Apr; 161(1-3):97-105. doi: 10.1016/j.regpep.2010.02.003. [PMID: 20171995]
  • Jennyfer Cázares-Delgadillo, Adriana Ganem-Rondero, David Quintanar-Guerrero, Alicia C López-Castellano, Virginia Merino, Yogeshvar N Kalia. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2010 Mar; 39(5):387-93. doi: 10.1016/j.ejps.2010.01.008. [PMID: 20096354]
  • Julian Howell, Jean Smeets, Henk-Jan Drenth, David Gill. Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2009 Dec; 15(4):223-31. doi: 10.1177/1078155209104063. [PMID: 19304880]
  • Mélanie Bergeron, Annik Bergeron, Milton Furtado, Fabio Garofolo. Impact of plasma and whole-blood anticoagulant counter ion choice on drug stability and matrix effects during bioanalysis. Bioanalysis. 2009 Jun; 1(3):537-48. doi: 10.4155/bio.09.74. [PMID: 21083151]
  • Mitsue Saito, Kenjiro Aogi, Ikuo Sekine, Hirohisa Yoshizawa, Yasuhiro Yanagita, Hiroshi Sakai, Kenichi Inoue, Chiyoe Kitagawa, Takashi Ogura, Shoichi Mitsuhashi. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. The Lancet. Oncology. 2009 Feb; 10(2):115-24. doi: 10.1016/s1470-2045(08)70313-9. [PMID: 19135415]
  • Andrew J Thompson, Sarah C R Lummis. Calcium modulation of 5-HT3 receptor binding and function. Neuropharmacology. 2009 Jan; 56(1):285-91. doi: 10.1016/j.neuropharm.2008.07.009. [PMID: 18675830]
  • Susumu Nakade, Tomoya Ohno, Junsaku Kitagawa, Yoshitaka Hashimoto, Masahiro Katayama, Hiroshi Awata, Yasuo Kodama, Yasuyuki Miyata. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting. Cancer chemotherapy and pharmacology. 2008 Dec; 63(1):75-83. doi: 10.1007/s00280-008-0713-y. [PMID: 18317761]
  • Alfonso Gurpide, Belen Sadaba, Salvador Martin-Algarra, Jose R Azanza, Jose M Lopez-Picazo, Miguel A Campanero, Juan P Cabello, Isabel Gil-Aldea, Susana de la Cruz, Victor Fernandez Gallego, Carmen Reyna, Clara Olier Garate, María J Blanco-Prieto, Jaime Ceballos, Jesus Garcia-Foncillas, Jose L Perez-Gracia. Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy. The oncologist. 2007 Sep; 12(9):1151-5. doi: 10.1634/theoncologist.12-9-1151. [PMID: 17914085]
  • Valérie Kayser, Iskander Elfihri Elfassi, Bertrand Aubel, Maxette Melfort, David Julius, Jay A Gingrich, Michel Hamon, Sylvie Bourgoin. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain. 2007 Aug; 130(3):235-248. doi: 10.1016/j.pain.2006.11.015. [PMID: 17250964]
  • Pouran Layegh, Mohammad Javad Mojahedi, Parisa Emamgholi Tabar Malekshah, Fakhrozaman Pezeshkpour, Mohamad Vahedian, Fatemeh Nazemian, Farzaneh Sharifi Pour. Effect of oral granisetron in uremic pruritus. Indian journal of dermatology, venereology and leprology. 2007 Jul; 73(4):231-4. doi: 10.4103/0378-6323.32887. [PMID: 17675729]
  • Jong Soo Woo. Nasal absorption studies of granisetron in rats using a validated high-performance liquid chromatographic method with mass spectrometric detection. Archives of pharmacal research. 2007 Jun; 30(6):778-84. doi: 10.1007/bf02977642. [PMID: 17679558]
  • Yi Chen, Haijun Miao, Mei Lin, Guorong Fan, Zhanying Hong, Huiling Wu, Yutian Wu. Development and validation of a selective and robust LC-MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: application to a clinical pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2006 Dec; 844(2):268-77. doi: 10.1016/j.jchromb.2006.07.027. [PMID: 16899417]
  • Yunyun Jiang, Mei Lin, Guorong Fan, Yi Chen, Zhen Li, Weiquan Zhao, Yutian Wu, Jinhong Hu. Rapid determination of granisetron in human plasma by liquid chromatography coupled to tandem mass spectrometry and its application to bioequivalence study. Journal of pharmaceutical and biomedical analysis. 2006 Oct; 42(4):464-73. doi: 10.1016/j.jpba.2006.05.001. [PMID: 16784831]
  • Ramakrishna V S Nirogi, Vishwottam N Kandikere, Manoj Shukla, Koteshwara Mudigonda, Santosh Maurya, Ravikumar Boosi. Quantification of granisetron in human plasma by liquid chromatography coupled to electrospray tandem mass spectrometry. Biomedical chromatography : BMC. 2006 Sep; 20(9):888-97. doi: 10.1002/bmc.613. [PMID: 16389637]
  • Masanori Miyata, Kazuhito Yasuda, Naoto Burioka, Hiroshi Takane, Hisashi Suyama, Yasushi Shigeoka, Masahiro Endo, Jun Kurai, Masato Morita, Tadashi Igishi, Eiji Shimizu. The influence of granisetron on the pharmacokinetics and pharmacodynamics of docetaxel in Asian lung cancer patients. Cancer journal (Sudbury, Mass.). 2006 Jan; 12(1):69-72. doi: 10.1097/00130404-200601000-00012. [PMID: 16613665]
  • Andrew J Thompson, Kerry L Price, David C Reeves, S Ling Chan, P-L Chau, Sarah C R Lummis. Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding. The Journal of biological chemistry. 2005 May; 280(21):20476-82. doi: 10.1074/jbc.m413610200. [PMID: 15781467]
  • Nikolaos Christidis, Sigvard Kopp, Malin Ernberg. The effect on mechanical pain threshold over human muscles by oral administration of granisetron and diclofenac-sodium. Pain. 2005 Feb; 113(3):265-270. doi: 10.1016/j.pain.2004.10.016. [PMID: 15661432]
  • Robert A Blum, Anup Majumdar, Jacqueline McCrea, John Busillo, Laura H Orlowski, Deborah Panebianco, Michael Hesney, Kevin J Petty, Michael R Goldberg, M Gail Murphy, Kevin M Gottesdiener, Carolyn M Hustad, Christian Lates, Walter K Kraft, Sandi Van Buren, Scott A Waldman, Howard E Greenberg. Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects. Clinical therapeutics. 2003 May; 25(5):1407-19. doi: 10.1016/s0149-2918(03)80128-5. [PMID: 12867217]
  • Amnon C Sintov, Igor Krymberk, Dorit Daniel, Talli Hannan, Ze'ev Sohn, Galit Levin. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. Journal of controlled release : official journal of the Controlled Release Society. 2003 Apr; 89(2):311-20. doi: 10.1016/s0168-3659(03)00123-8. [PMID: 12711453]
  • I Wada, T Takeda, M Sato, H Saitoh, T Nakabayashi, K Mino, T Honma, M Takada, K Hirano. Pharmacokinetics of granisetron in adults and children with malignant diseases. Biological & pharmaceutical bulletin. 2001 Apr; 24(4):432-5. doi: 10.1248/bpb.24.432. [PMID: 11305610]
  • U Ladabaum, M B Brown, W Pan, C Owyang, W L Hasler. Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans. American journal of physiology. Gastrointestinal and liver physiology. 2001 Feb; 280(2):G201-8. doi: 10.1152/ajpgi.2001.280.2.g201. [PMID: 11208541]
  • O Voog, P Alstergren, E Leibur, R Kallikorm, S Kopp. Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders. Life sciences. 2000 Dec; 68(5):591-602. doi: 10.1016/s0024-3205(00)00965-6. [PMID: 11197756]
  • A M Castejon, X Paez, L Hernandez, L X Cubeddu. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron. The Journal of pharmacology and experimental therapeutics. 1999 Dec; 291(3):960-6. doi: NULL. [PMID: 10565811]
  • F Marquet, D Pansu, M Descroix-Vagne. Distant intestinal stimulation by cholera toxin in rat in vivo. European journal of pharmacology. 1999 Jun; 374(1):103-11. doi: 10.1016/s0014-2999(99)00286-1. [PMID: 10422646]
  • E S Björnsson, W D Chey, U Ladabaum, M L Woods, F G Hooper, C Owyang, W L Hasler. Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex. The American journal of physiology. 1998 09; 275(3):G498-505. doi: 10.1152/ajpgi.1998.275.3.g498. [PMID: 9724261]
  • I Wada, M Satoh, T Takeda, T Nakabayashi, T Honma, H Saitoh, M Takada, K Hirano. A rapid assay of granisetron in biological fluids from cancer patients. Biological & pharmaceutical bulletin. 1998 May; 21(5):535-7. doi: 10.1248/bpb.21.535. [PMID: 9635515]
  • O Lehoczky. Report on the antiemetic effectivity of a single 1 mg oral granisetron in moderately emetogenic chemotherapies of gynecological malignancies. European journal of gynaecological oncology. 1998; 19(5):449-52. doi: NULL. [PMID: 9863909]
  • T A Benline, J French. Anti-emetic drug effects on cognitive and psychomotor performance: granisetron vs. ondansetron. Aviation, space, and environmental medicine. 1997 Jun; 68(6):504-11. doi: NULL. [PMID: 9184738]
  • S Ozono, E Okajima, Y K Hirao, O Natsume, Y Kaneko, S Ohara, S Tabata, S Watanabe, H Aoyama, K Sasaki, H Matsuki, K Takashima, Y Maruyama, M Yoshikawa, K Yamada, H Momose, T Hiramatsu, Y Hayashi, K Babaya, T Shiomi. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group]. Gan to kagaku ryoho. Cancer & chemotherapy. 1997 Feb; 24(3):349-56. doi: NULL. [PMID: 9051139]
  • J Kigawa, Y Minagawa, H Itamochi, X Cheng, M Okada, N Terakawa. Combination effect of granisetron and methylprednisolone for preventing emesis induced by cytotoxic agents. Gynecologic and obstetric investigation. 1997; 43(3):195-9. doi: 10.1159/000291853. [PMID: 9127135]
  • A C Hargreaves, M J Gunthorpe, C W Taylor, S C Lummis. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels. Molecular pharmacology. 1996 Nov; 50(5):1284-94. doi: . [PMID: 8913360]
  • A G Hope, J A Peters, A M Brown, J J Lambert, T P Blackburn. Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells. British journal of pharmacology. 1996 Jul; 118(5):1237-45. doi: 10.1111/j.1476-5381.1996.tb15529.x. [PMID: 8818349]
  • V K Boppana, C Miller-Stein, W H Schaefer. Direct plasma liquid chromatographic-tandem mass spectrometric analysis of granisetron and its 7-hydroxy metabolite utilizing internal surface reversed-phase guard columns and automated column switching devices. Journal of chromatography. B, Biomedical applications. 1996 Apr; 678(2):227-36. doi: 10.1016/0378-4347(95)00480-7. [PMID: 8738026]
  • F Pinguet, F Bressolle, P Martel, D Salabert, C Astre. High-performance liquid chromatographic determination of granisetron in human plasma. Journal of chromatography. B, Biomedical applications. 1996 Jan; 675(1):99-105. doi: 10.1016/0378-4347(95)00335-5. [PMID: 8634776]
  • F H Mourad, L J O'Donnell, J A Dias, E Ogutu, E A Andre, J L Turvill, M J Farthing. Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut. 1995 Sep; 37(3):340-5. doi: 10.1136/gut.37.3.340. [PMID: 7590428]
  • F H Mourad, L J O'Donnell, E Ogutu, J A Dias, M J Farthing. Role of 5-hydroxytryptamine in intestinal water and electrolyte movement during gut anaphylaxis. Gut. 1995 Apr; 36(4):553-7. doi: 10.1136/gut.36.4.553. [PMID: 7737563]
  • V K Boppana. Simultaneous determination of granisetron and its 7-hydroxy metabolite in human plasma by reversed-phase high-performance liquid chromatography utilizing fluorescence and electrochemical detection. Journal of chromatography. A. 1995 Feb; 692(1-2):195-202. doi: 10.1016/0021-9673(94)00842-w. [PMID: 7719453]
  • J Carmichael, P A Philip, C Forfar, A L Harris. An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3 mg over 30 s in patients receiving chemotherapy for malignant disease. Cancer chemotherapy and pharmacology. 1995; 37(1-2):134-8. doi: 10.1007/bf00685640. [PMID: 7497582]
  • A Allen, P Crome, C C Davie, M Davy, R W Jones, D M Pierce, J Upward, P Wijayawardhana. The pharmacokinetics of granisetron, a 5-HT3 antagonist in healthy young and elderly volunteers. European journal of clinical pharmacology. 1995; 48(6):519-20. doi: 10.1007/bf00194344. [PMID: 8582473]
  • S E Clarke, N E Austin, J C Bloomer, R E Haddock, F C Higham, F J Hollis, M Nash, P C Shardlow, T C Tasker, F R Woods. Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica; the fate of foreign compounds in biological systems. 1994 Nov; 24(11):1119-31. doi: 10.3109/00498259409038671. [PMID: 7701853]
  • S Kudoh, T Sato, H Okada, H Kumakura, H Nakamura. Simultaneous determination of granisetron and 7-hydroxygranisetron in human plasma by high-performance liquid chromatography with fluorescence detection. Journal of chromatography. B, Biomedical applications. 1994 Oct; 660(1):205-10. doi: 10.1016/0378-4347(94)00262-2. [PMID: 7858717]
  • S Noguchi, Y Kubota, T Shuin, M Masuda, H Misaki, M Yao, K Kondoh, T Sakuramoto, M Hosaka. [M-VAC chemotherapy for advanced urothelial cancer--side effects and their management]. Hinyokika kiyo. Acta urologica Japonica. 1994 Aug; 40(8):677-82. doi: NULL. [PMID: 7942364]
  • M R Perry, J Rhee, W L Smith. Plasma levels of peptide YY correlate with cisplatin-induced emesis in dogs. The Journal of pharmacy and pharmacology. 1994 Jul; 46(7):553-7. doi: 10.1111/j.2042-7158.1994.tb03855.x. [PMID: 7996381]
  • A Allen, C C Asgill, D M Pierce, J Upward, B D Zussman. Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects. European journal of clinical pharmacology. 1994; 46(2):159-62. doi: 10.1007/bf00199881. [PMID: 8039536]
  • D Cupissol, F Bressolle, L Adenis, J Carmichael, E Bessell, A Allen, M Wargenau, D Romain. Evaluation of the bioequivalence of tablet and capsule formulations of granisetron in patients undergoing cytotoxic chemotherapy for malignant disease. Journal of pharmaceutical sciences. 1993 Dec; 82(12):1281-4. doi: 10.1002/jps.2600821221. [PMID: 8308713]
  • A Hiraoka, T Masaoka, K Nagai, E Kakishita, S Oshiba, T Kageyama, K Okuda, N Tatsumi, H Uchino, Y Matsuzawa. [Granisetron oral phase III clinical trial--study on the inhibitory effect of granisetron for nausea/vomiting induced by chemotherapy for tumors in the hematopoietic organs]. Gan to kagaku ryoho. Cancer & chemotherapy. 1993 Sep; 20(12):1835-41. doi: NULL. [PMID: 8397489]
  • H Matsuishi, M Harada, H Gondo, T Otsuka, T Teshima, Y Yamano, F Omori, T Shibuya, K Yamazaki, S Taniguchi. [Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs]. Gan to kagaku ryoho. Cancer & chemotherapy. 1993 Aug; 20(10):1339-48. doi: NULL. [PMID: 8394061]
  • N J Brown, A Horton, R D Rumsey, N W Read. Granisetron and ondansetron: effects on the ileal brake mechanism in the rat. The Journal of pharmacy and pharmacology. 1993 Jun; 45(6):521-4. doi: 10.1111/j.2042-7158.1993.tb05591.x. [PMID: 8103099]
  • B R Capacio, C E Byers, T K Jackson, R L Matthews. An HPLC method for the determination of granisetron in guinea pig plasma. Journal of analytical toxicology. 1993 May; 17(3):151-5. doi: 10.1093/jat/17.3.151. [PMID: 8393119]
  • D K Sommers, J R Snyman, M van Wyk. Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man. European journal of clinical pharmacology. 1993; 44(4):337-9. doi: 10.1007/bf00316469. [PMID: 8390368]
  • P I Thompson, S Bingham, P L Andrews, N Patel, S P Joel, M L Slevin. Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret. British journal of pharmacology. 1992 May; 106(1):3-8. doi: 10.1111/j.1476-5381.1992.tb14284.x. [PMID: 1324067]
  • N J Brown, S J French, R D Rumsey, N W Read. The effect of a 5-HT3-antagonist on the ileal brake mechanism in the rat. The Journal of pharmacy and pharmacology. 1991 Jul; 43(7):517-9. doi: 10.1111/j.2042-7158.1991.tb03527.x. [PMID: 1682469]
  • Z Itoh, A Mizumoto, Y Iwanaga, N Yoshida, K Torii, K Wakabayashi. Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog. Gastroenterology. 1991 Apr; 100(4):901-8. doi: 10.1016/0016-5085(91)90262-j. [PMID: 1848200]
  • N Yoshida, A Mizumoto, Y Iwanaga, Z Itoh. Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs. The Journal of pharmacology and experimental therapeutics. 1991 Jan; 256(1):272-8. doi: . [PMID: 1846418]
  • M Addelman, C Erlichman, S Fine, D Warr, C Murray. Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Feb; 8(2):337-41. doi: 10.1200/jco.1990.8.2.337. [PMID: 2153767]
  • J W Upward, B D Arnold, C Link, D M Pierce, A Allen, T C Tasker. The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist. European journal of cancer (Oxford, England : 1990). 1990; 26 Suppl 1(?):S12-5. doi: . [PMID: 2169778]
  • J Carmichael, B M Cantwell, C M Edwards, B D Zussman, S Thompson, W G Rapeport, A L Harris. A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response. Cancer chemotherapy and pharmacology. 1989; 24(1):45-9. doi: 10.1007/bf00254104. [PMID: 2541937]
  • J Cassidy, V Raina, C Lewis, L Adams, M Soukop, W G Rapeport, B D Zussman, E M Rankin, S B Kaye. Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist. British journal of cancer. 1988 Nov; 58(5):651-3. doi: 10.1038/bjc.1988.278. [PMID: 2851312]